MetLife, Inc.

New York Stock Exchange
Back to all articles
Bullish +55

31,400 Shares in MetLife, Inc. $MET Bought by Andra AP fonden

AI-generated analysis

📈 Andra AP fonden purchased a new position in MetLife consisting of 31,400 shares valued at approximately $2.22 million during the first quarter.

📊 Activest Wealth Management increased its holdings by 205.8% in the fourth quarter, while Sound Income Strategies LLC boosted its stake by 58.9%.

📈 Jefferies Financial Group raised its price target to $103 and TD Cowen increased its objective to $105, both maintaining buy ratings.

💰 MetLife reported quarterly EPS of $2.42, beating analyst estimates of $2.27, though revenue of $14.18 billion missed the consensus forecast of $19.49 billion.

📉 The stock has a 52-week high of $94.86 and a low of $67.33, currently trading with a market cap of $59.61 billion.

💵 MetLife declared a quarterly dividend of $0.5925 per share, representing an annualized yield of 2.6% payable on September 8th.

🏦 The company operates as a global provider of insurance, annuities, and employee benefit programs with headquarters in New York City.

📉 Revenue for the quarter was up 2.7% compared to the same period last year despite missing absolute analyst expectations.

Bullish Signals
  • Andra AP fonden initiated a significant new position of $2.22 million, signaling strong institutional confidence in the company.
  • Activest Wealth Management increased its stake by over 200% and Sound Income Strategies LLC boosted holdings by nearly 60% in the fourth quarter.
  • Jefferies Financial Group raised its price target to $103 and TD Cowen lifted its objective to $105, both reaffirming buy ratings.
  • Weiss Ratings upgraded MetLife from a 'buy (b-)' to a 'buy (b)', indicating improved credit or fundamental outlook.
  • MetLife beat quarterly earnings per share estimates with reported EPS of $2.42 versus the consensus of $2.27.
  • The company maintains a solid dividend yield of 2.6% with a payout ratio of 45.93%, providing income to shareholders.
  • Revenue grew by 2.7% year-over-year to $14.18 billion, demonstrating organic business growth despite missing absolute targets.
  • The average analyst price target of $100.50 suggests potential upside from recent trading levels.
Risk Factors
  • MetLife's quarterly revenue of $14.18 billion significantly missed the analyst consensus estimate of $19.49 billion.
  • Bank of America lowered its price target on MetLife shares from $103.00 to $99.00, though it maintained a buy rating.
Full Analysis
Andra AP fonden established a new position in MetLife, Inc. (NYSE:MET) by purchasing 31,400 shares valued at approximately $2.22 million during the first quarter, according to recent SEC filings. Several other institutional investors also increased their stakes in the fourth quarter, including Activest Wealth Management which lifted its holdings by over 200%, and Sound Income Strategies LLC which boosted its stake by nearly 60%. These new positions indicate growing institutional interest in the financial services provider. Analyst sentiment remains predominantly positive with major firms raising price targets and maintaining buy ratings. Jefferies Financial Group increased its target price to $103, while TD Cowen raised its objective to $105. Weiss Ratings upgraded MetLife from a 'buy (b-)' to a 'buy (b)', and UBS Group lifted its price objective to $105. The consensus average rating is currently a 'Moderate Buy' with an average target price of $100.50, suggesting analysts see potential upside from current levels. MetLife recently reported earnings for the quarter ended May 6th, posting EPS of $2.42 which beat analyst estimates of $2.27. However, revenue came in at $14.18 billion, significantly below the consensus estimate of $19.49 billion, though it represented a 2.7% year-over-year increase. The company maintains a market capitalization of $59.61 billion and has declared a quarterly dividend of $0.5925 per share payable on September 8th to shareholders of record on August 4th.